Antiplatelet therapy with or without PPIs for the secondary prevention of cardiovascular diseases in patients at high risk of upper gastrointestinal bleeding: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Antiplatelet therapy with or without PPIs for the secondary prevention of cardiovascular diseases in patients at high risk of upper gastrointestinal bleeding: A systematic review and meta-analysis

Published:2020-04-09 Issue: Volume: Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Wu Wenfa¹,Liu Jia²,Yu Huiwen¹,Jiang Zuofeng¹

Affiliation:

1. Department of General Practice, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, Guangdong 510220, P.R. China

2. Department of VIP Medical Center, the Third Affiliated Hospital, Medical College, Sun Yat-sen University, Guangzhou, Guangdong 510220, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS);Zeitschrift für Gastroenterologie;2024-02

2. Concomitant Use of Antiplatelet Agents and Proton-Pump Inhibitors Increases the Risk of Adverse Cardiovascular Events: A Nationwide Population-Based Cohort Study Using Balanced Operational Definitions;Journal of Cardiovascular Development and Disease;2023-06-20

3. Aktualisierte S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – Juli 2022 – AWMF-Registernummer: 021–001;Zeitschrift für Gastroenterologie;2023-05

4. Mean platelet volume modifies the contribution of homocysteine to cardiovascular disease: A real-world study;Nutrition, Metabolism and Cardiovascular Diseases;2023-01

5. Cost-Effectiveness and cost–utility analysis of the use of clopidogrel and pantoprazole in comparison with clopidogrel and omeprazole for the secondary prevention of myocardial infarction in Iran;Journal of Research in Pharmacy Practice;2021